Clinical trial
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary…
NCT00058929 · United Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00058929 |
|---|---|
| Title | A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension |
| Official title | A Multicenter, Randomized, Parallel Placebo-Controlled Study of the Safety and Efficacy of Subcutaneous Remodulin® Therapy After Transition From Flolan® in Patients With Pulmonary Arterial Hypertension |
| Lead sponsor | United Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | treprostinil sodium |
| Enrollment | 39 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Apr 16, 2003 |
| Last update posted | Mar 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: